New Drug Review: Anjeso

Inbox

x

MPR First Look <editor@email.empr.com> Unsubscribe

7:18 PM (3 hours ago)

to me

If you are having trouble viewing this email, click here.

NEW DRUG PRODUCT: ANJESO FEATURED Find out more about Anjeso including dosing and important safety information with our slideshow, complete drug monograph, and downloadable PDF. DRUGS IN THE PIPELINE Nivolumab Plus Ipilimumab Under Review for First-Line Treatment of NSCLC Novel Meloxicam/Rizatriptan Combo Superior to Placebo in Migraine Trial Pedmark Receives Priority Review for Prevention of Cisplatin-Induced Ototoxicity Serlopitant Not Statistically Significantly Better Than Placebo in Prurigo Nodularis Studies Vutrisiran Fast-Tracked for Polyneuropathy of hATTR Amyloidosis The right dose of information. eMPR.com Featured Content Collection and Use of Real-World Data Continues to Grow Around the World CME/CE Spotlight A Multidisciplinary Approach to the Management of Psoriatic Arthritis AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists CLICK HERE FOR A FULL LIST OF COURSES CE/CME Powered By myCME